Mayan Katz is an associate in Goodwin’s Technology and Life Sciences group. Mr. Katz engages in a broad-based corporate practice, with an emphasis on the pharmaceutical, medical device and biotechnology sectors. He has extensive experience representing and advising life sciences and technology companies, funds and investors in connection with M&A, divestitures, joint ventures, venture capital investments and public offerings. He also advises clients on corporate, securities and transactional matters. Mr. Katz joined the firm in 2018.

Areas of Practice
Domaines D’Expertise





Significant representations include:

Life Sciences

  • Johnson and Johnson UK Treasury Company Limited as lead investor of the $1.3 billion Series B financing of Grail, Inc., which was named LMG Life Sciences 2017 “Impact Deal of the Year”*
  • Zealand Pharma in its upsized $90 million IPO on The NASDAQ Global Select Market.*
  • Janssen Pharmaceutical NV, a wholly-owned subsidiary of Johnson & Johnson, in its $155 million sale of injectable anesthesia and pain management products to Piramal Enterprises’ critical care division.*
  • Acclarent, Inc., a wholly-owned subsidiary of Johnson & Johnson in its spinout of Tusker Medical Inc. to Apple Tree Partners.*
  • A wholly-owned subsidiary of an S&P 500 pharmaceutical company in its equity and debt financing of a private life sciences company.*
  • An affiliate of a leading biopharmaceutical company in an asset spin off and a collaboration and license agreement with a company co-founded by a US-based investment firm.*
  • A healthcare company in its reorganization and series seed financing.*
  • A multinational medical device company in its $51 million acquisition of assets and a subsequent joint venture.


  • E-commerce company Lazada Group on the $1 billion sale of a controlling stake in the company to Alibaba, which was named “M&A Deal of the Year: Southeast Asia” at The Asian Lawyer’s 2017 Asia Legal Awards.*
  • A leading 3D printing company on a series of substantial acquisitions for $695 million.*
  • A leading 3D printing company in its $481 million follow-on public offering on NASDAQ.*
  • A leading 3D printing company in its merger and subsequent registration statement on NASDAQ.*
  • A multinational technology corporation on a series of cross-border acquisitions.*
  • A private Israeli company in its $15.5 million Series B financing from several venture capital funds.*

Mergers and Acquisitions

  • A multinational conglomerate holding company in the $475 million sale of its subsidiary to a Fortune 500 global manufacturing and marketing company.*
  • A private equity firm in its investment in a leading Mid-Atlantic eye care platform.*
  • A private equity firm in its acquisition of a Georgia-based wholesale and direct-to-consumer distributor of value-oriented furniture.*

* Denotes experience prior to joining Goodwin.

Professional Experience

Prior to joining Goodwin in 2018, Mr. Katz was an associate at Dechert LLP in New York and at Meitar Liquornik Geva Leshem Tal in Tel Aviv.

While attending law school, Mr. Katz was the Editor-in-Chief (Vol. 34) and an Editorial Board Member (Vol. 33) of Tel Aviv University Law Review (Iyunei Misphat).

Prior to his studies at Tel Aviv University, Mr. Katz served as an officer in the Israel Defense Forces.

In The News









LL.M., 2015
University of Pennsylvania Law School

(with distinction)

(Dean’s Scholarship Award)

LL.B., 2011
Tel Aviv University

(Dean’s Honor List for 2009)

B.A., Economics, 2011
Tel Aviv University



New York





Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique